LOADING
Comparing Johnson & Johnson (JNJ) and Intel Corporation (INTC) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | INTC |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $555.2B | $335.3B |
| P/E Ratio | 26.7 | -- |
| Forward P/E | 20.0 | 125.0 |
| PEG Ratio | 3.01 | 0.50 |
| EPS | $8.63 | $-0.06 |
| Revenue Growth (YoY) | 9.9% | -4.1% |
| Profit Margin | 21.8% | -0.5% |
| Return on Equity | 35.0% | 0.0% |
| Dividend Yield | 2.30% | -- |
| Beta | 0.33 | 1.35 |
| 52-Week High | $251.71 | $70.33 |
| 52-Week Low | $142.16 | $18.96 |
| Volume | -- | -- |
Johnson & Johnson is the larger company by market capitalization. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.